
The Non-coding RNA journal webinar is open to all who enjoy doing any type of research on the topic of non-coding transcripts, or are passionate about learning about this exciting and competitive research area. The webinar speakers will present new findings from basic to translational research. Any interesting ideas for topics and speakers are welcomed!
Date: 8 February 2022
Time: 4:00pm CET | 10:00am EST | 11:00pm CST Asia
Webinar ID: 846 6923 4695
Webinar Secretariat: ncrna.webinar@mdpi.com
Department of Translational Molecular Pathogenesis, Center for RNA Interference and Non-coding RNAs, University of Texas MD Anderson Cancer Center, Houston, USA;
Prof. Dr. George A. Calin received both his M.D. and Ph.D. degrees at Carol Davila University of Medicine in Bucharest, Romania. After working in cytogenetics as an undergraduate student with Dragos Stefanescu in Bucharest, Calin completed cancer genomics training in Massimo Negrini’s laboratory at the University of Ferrara, Italy, and in 2000, he became a postdoctoral fellow in Carlo Croce’s laboratory at Kimmel Cancer Center in Philadelphia, Pennsylvania. In June 2007, Calin joined MD Anderson as an associate professor in the Experimental Therapeutics department and was promoted to Professor with tenure in 2013. He explores new RNA therapeutic options for cancer patients and studies the roles of microRNAs and other non-coding RNAs in cancer initiation and progression, as well as the mechanisms of cancer predisposition.
On Tuesday, 8 February 2021, MDPI and the Journal ncRNA organized the1st webinar on ncRNA, entitled "MicroRNA in Cancer Pathogenesis".
The introduction was held by the Chair of the webinar, Prof. Dr. George A. Calin, a Professor of the University of Texas MD Anderson Cancer Center in Houston, United States. He explores new RNA therapeutic options for cancer patients and studies the roles of microRNAs and other non-coding RNAs in cancer initiation and progression, as well as the mechanisms of cancer predisposition.
The speaker for this webinar was Prof. Dr. Carlo M. Croce. In his scientific career, Prof. Croce has studied various aspects of human cancer genetics. His lab at the Ohio State University College of Medicine in Columbus (United States) researches early changes of malignancy and how they might serve as targets for new treatment and preventive agents.
The presentations were followed by a Q&A and a discussion. The webinar was offered via Zoom and required registration to attend. The full recording can be found here on Sciforum website. In order to stay updated on the next webinars on ncRNA, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.